Strategic Collaboration with MD Anderson Cancer Center
VG161 US IND approval; VG201 US IND approval
Initiated construction of R&D and Manufacturing Center, Shanghai
CNBG-Virogin Joint Venture established
Virogin Biotech Australia established
Shanghai Virogin Biotech established
Seed Financing; Shenzhen Virogin Biotech established
Virogin Biotech Hong Kong established; Virogin Biotech Canada established